Revenue increased 9.0%
Revenue changed +9.0% from the comparable as-filed period.
$13.2B→$14.4B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HPQ financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 37.3%
Cash & equivalents changed +37.3% from the comparable as-filed period.
$2.7B→$3.7B3 prior comparisons
Debt decreased 41.8%
Debt changed -41.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.4B→$810.0M4 prior comparisons
Gross profit increased 10.1%
Gross profit changed +10.1% from the comparable as-filed period.
$2.7B→$3.0B3 prior comparisons
Inventory increased 12.6%
Inventory changed +12.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.2B→$9.2B4 prior comparisons
Research & development increased 7.7%
Research & development changed +7.7% from the comparable as-filed period.
$401.0M→$432.0M3 prior comparisons
Net income increased 10.8%
Net income changed +10.8% from the comparable as-filed period.
$406.0M→$450.0M2 prior comparisons
Operating income decreased 6.4%
Operating income changed -6.4% from the comparable as-filed period.
$654.0M→$612.0M3 prior comparisons
Gross margin moved 21 bp higher
Gross margin changed +21 basis points from the comparable as-filed period.
20.72%→20.93%3 prior comparisons
Operating margin moved 70 bp lower
Operating margin changed -70 basis points from the comparable as-filed period.
4.95%→4.25%3 prior comparisons
Selling, general & administrative increased 2.3%
Selling, general & administrative changed +2.3% from the comparable as-filed period.
$1.5B→$1.5B3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.